Autoinflammatory Diseases and COVID-19 Vaccination: Analysis of SARS-CoV-2 Anti-S-RBD IgG Levels in a Cohort of Patients Receiving IL-1 Inhibitors

The purpose of the study was to evaluate the antibody response after COVID-19 vaccination in patients affected by systemic autoinflammatory diseases (SAID) undertaking IL-1 inhibitors (IL-1i) compared to healthy vaccinated controls (HC). The course of COVID-19 in vaccinated patients on IL-1i was als...

Descripción completa

Detalles Bibliográficos
Autores principales: Bindoli, Sara, Baggio, Chiara, Galozzi, Paola, Vesentini, Filippo, Doria, Andrea, Cosma, Chiara, Padoan, Andrea, Sfriso, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380649/
https://www.ncbi.nlm.nih.gov/pubmed/37510856
http://dx.doi.org/10.3390/jcm12144741

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380649/
https://www.ncbi.nlm.nih.gov/pubmed/37510856
http://dx.doi.org/10.3390/jcm12144741

Ejemplares similares